SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.35-0.8%Dec 2 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob zagorin who wrote (29131)8/13/1999 9:11:00 PM
From: Cacaito  Read Replies (1) of 32384
 
businesswire.com, check Rosiglitazone
news. (Avandia from SKB).

It showed good effects against ulcerative colitis, this is a very interesting action of this tioglitazone.

Maybe Ligand's tiolglitazone (3rd generations)will also show similar effects. Maybe.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext